Johnson & Johnson CARVYKTI — Percent Change (as a percent) decreased by 20.7% to 136.8% in Q3 2025 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase reflects accelerating adoption or market expansion, whereas a decrease suggests a deceleration in growth or potential loss of market share.
This metric measures the period-over-period percentage growth or decline in net sales for a specific therapeutic product...
Comparable to year-over-year or sequential product growth rates reported by pharmaceutical companies for their key growth drivers.
jnj_segment_carvykti_percent_change_as_a_percent| Q2 '24 | Q3 '24 | Q3 '25 | |
|---|---|---|---|
| Value | 106.3% | 172.6% | 136.8% |
| QoQ Change | — | +62.4% | -20.7% |
| YoY Change | — | — | -20.7% |
We use cookies for analytics. See our Privacy and Cookie Policy.